Tarasaponin IV

CAS# 156980-31-3

Tarasaponin IV

Catalog No. BCX1264----Order now to get a substantial discount!

Product Name & Size Price Stock
Tarasaponin IV: 5mg Please Inquire In Stock
Tarasaponin IV: 10mg Please Inquire In Stock
Tarasaponin IV: 20mg Please Inquire Please Inquire
Tarasaponin IV: 50mg Please Inquire Please Inquire
Tarasaponin IV: 100mg Please Inquire Please Inquire
Tarasaponin IV: 200mg Please Inquire Please Inquire
Tarasaponin IV: 500mg Please Inquire Please Inquire
Tarasaponin IV: 1000mg Please Inquire Please Inquire

Quality Control of Tarasaponin IV

Number of papers citing our products

Chemical structure

Tarasaponin IV

3D structure

Chemical Properties of Tarasaponin IV

Cas No. 156980-31-3 SDF Download SDF
PubChem ID 56683127.0 Appearance Powder
Formula C53H84O23 M.Wt 1089.23
Type of Compound Triterpenoids Storage Desiccate at -20°C
Solubility Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc.
Chemical Name (2S,3S,4S,5R,6R)-6-[[(3S,4aR,6aR,6bS,8aS,12aS,14aR,14bR)-4,4,6a,6b,11,11,14b-heptamethyl-8a-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxycarbonyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-3-[(2S,3R,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-4-hydroxy-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxane-2-carboxylic acid
SMILES CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)OC6C(C(C(C(O6)C(=O)O)OC7C(C(C(O7)CO)O)O)O)OC8C(C(C(C(O8)CO)O)O)O)C)C)C2C1)C)C(=O)OC9C(C(C(C(O9)CO)O)O)O)C
Standard InChIKey XYCUSPPPIYQSLD-MPZQIDBGSA-N
Standard InChI InChI=1S/C53H84O23/c1-48(2)14-16-53(47(68)76-45-37(64)34(61)31(58)25(20-55)71-45)17-15-51(6)22(23(53)18-48)8-9-28-50(5)12-11-29(49(3,4)27(50)10-13-52(28,51)7)72-46-40(74-44-36(63)33(60)30(57)24(19-54)69-44)38(65)39(41(75-46)42(66)67)73-43-35(62)32(59)26(21-56)70-43/h8,23-41,43-46,54-65H,9-21H2,1-7H3,(H,66,67)/t23-,24+,25+,26-,27-,28+,29-,30+,31+,32-,33-,34-,35+,36+,37+,38-,39-,40+,41-,43-,44-,45-,46+,50-,51+,52+,53-/m0/s1
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

Tarasaponin IV Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

Tarasaponin IV Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of Tarasaponin IV

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 0.9181 mL 4.5904 mL 9.1808 mL 18.3616 mL 22.952 mL
5 mM 0.1836 mL 0.9181 mL 1.8362 mL 3.6723 mL 4.5904 mL
10 mM 0.0918 mL 0.459 mL 0.9181 mL 1.8362 mL 2.2952 mL
50 mM 0.0184 mL 0.0918 mL 0.1836 mL 0.3672 mL 0.459 mL
100 mM 0.0092 mL 0.0459 mL 0.0918 mL 0.1836 mL 0.2295 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University
Featured Products
New Products
 

References on Tarasaponin IV

Oleanane-type triterpene saponins from the bark of Aralia elata and their NF-kappaB inhibition and PPAR activation signal pathway.[Pubmed:21889336]

Bioorg Med Chem Lett. 2011 Oct 15;21(20):6143-7.

Two new oleanane-type triterpene saponins, Tarasaponin IV (1) and elatoside L (2), and four known; stipuleanoside R(2) (3), kalopanax-saponin F (4), kalopanax-saponin F methylester (5), and elatoside D (6) were isolated from the bark of Aralia elata. Kalopanax-saponin F methyl ester was isolated from nature for the first time. Their chemical structures were elucidated using the chemical and physical methods as well as good agreement with those of reported in the literature. Oleanane-type triterpene saponins are the main component of A. elata. All compounds were investigated the anti-inflammatory activity. We measured their inhibition of NF-kappaB and activation of PPARs activities in HepG2 cells using luciferase reporter system. As results, compounds 2 and 4 were found to inhibit NF-kappaB activation stimulated by TNFalpha in a dose-dependent manner with IC(50) values of 4.1 and 9.5 muM, respectively, when compared with that of positive control, sulfasalazine (0.9 muM). Compounds 2 and 4 also inhibited TNFalpha-induced expression of iNOS and COX-2 mRNA. Furthermore, compounds 1-6 were evaluated PPAR activity using PPAR subtype transactivation assays. Among of them, compounds 4-6 significantly increased PPARgamma transactivation. However, compounds 4-6 did not activate in any other PPAR subtypes.

Keywords:

Tarasaponin IV,156980-31-3,Natural Products, buy Tarasaponin IV , Tarasaponin IV supplier , purchase Tarasaponin IV , Tarasaponin IV cost , Tarasaponin IV manufacturer , order Tarasaponin IV , high purity Tarasaponin IV

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: